Brookdale Senior Living vs Healthcare Services
BKD and HCSG side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BKD and HCSG compare
Brookdale Senior Living is the larger company, worth 1.3 times as much as Healthcare Services ($2.2B against $1.7B).
Healthcare Services grew revenue faster over the last twelve months (4.0% versus −8.4% for Brookdale Senior Living).
Healthcare Services keeps more of each dollar of sales as profit, with a net margin of 5.6% compared with −1.3% at Brookdale Senior Living.
Healthcare Services scores higher on the StockData Score (18 against 6 for Brookdale Senior Living), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BKD | HCSG |
|---|---|---|
| Size and price | ||
| Market cap | $2.2B | $1.7B |
| Share price | $9.17 | $24.90 |
| Change, 1 year | −12.7% | 40.7% |
| Change, 5 years | 37.9% | 34.2% |
| Beta (5Y) | 0.69 | 0.76 |
| Employees | 33K | 36K |
| StockData Score | ||
| Total score | 6 | 18 (better) |
| Valuation score | 2 | 5 (better) |
| Growth score | 1 | 4 (better) |
| Performance score | 2 | 3 (better) |
| Health score | 1 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 16.7× |
| P/S | 0.7× (better) | 0.9× |
| P/B | – | 3.2× |
| EV/EBITDA | 12.3× | 10.6× (better) |
| P/FCF | 151× | 15.7× (better) |
| PEG | – | 0.81 |
| FCF yield | 0.66% | 6.4% (better) |
| Fair value | – | $30.37 |
| Margin of safety | – | 18.0% |
| Growth | ||
| Revenue growth (TTM) | −8.4% | 4.0% (better) |
| Revenue growth, 5Y average | −2.0% | 0.86% (better) |
| Net income growth (TTM) | – | 164% |
| EPS growth (TTM) | – | 176% |
| EPS growth, 5Y average | – | −9.3% |
| Profitability | ||
| Gross margin | 27.6% (better) | 16.1% |
| Operating margin | 6.8% | – |
| Net margin | −1.3% | 5.6% (better) |
| FCF margin | 0.49% | 5.7% (better) |
| Return on equity | – | 20.4% |
| Return on invested capital | 4.0% | – |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Net debt / EBITDA | 7.95 | – |
| Current ratio | 1.05 | 2.82 (better) |
| Altman Z-score | −0.18 | 6.49 (better) |
| Piotroski F-score | 4 | 8 (better) |
| Dividends and buybacks | ||
| Buyback yield | – | 4.5% |
| Shareholder yield | 0.00% | 4.5% (better) |
| Ownership | ||
| Held by institutions | 114% | 108% |
| Held by insiders | 1.4% | 1.3% |
| Insider net buying, 12 months | $358K (better) | −$3.8M |
| Short interest, % of float | 17.8% | 3.7% |
Go deeper
- BKD stock overview
- BKD income statement
- BKD valuation and score
- HCSG stock overview
- HCSG income statement
- HCSG valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.